Mergers & Acquisitions Mergers & Acquisitions

EMS, Merck Sharp & Dohme, others queried about adequate market definition in União Química-Bayer deal review in Brazil

By Ana Paula Candil
  • 07 Jul 2021 11:11
  • 15 Jul 2021 10:08
EMS, Merck Sharp & Dohme Farmacêutica, Laboratórios Pfizer, Novartis Biociência and several other market players have been queried by the Brazilian competition authority about proper market definition in its review of União Química's planned buyout of Bayer's contraceptive business.

União Química aims to acquire Bayer's Schering do Brasil Química e Farmacêutica, as well

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News